1. Introduction
===============

Cardiovascular disease (CVD) is the leading cause of mortality, morbidity, and disability around the world ([@b1-epj-10-6775]). According to the increasing prevalence of CVD, diagnosis, timely treatment, and prevention of the complications are very substantial ([@b2-epj-10-6775]). It is important to identify symptomatic patients with obstructive coronary artery disease (CAD), especially the patients with left main and/or three-vessel CAD, due to appropriate medical treatment accompanied with revascularization result in the improvement of symptoms and patient's prognosis ([@b3-epj-10-6775]--[@b5-epj-10-6775]). Guidelines suggested stress echocardiography (SE) as a primary procedure for evaluation of established or suspected CAD patients ([@b6-epj-10-6775]). Dobutamine stress echocardiography (DSE) is a non-invasive technique to detect CVD ([@b7-epj-10-6775]). In other words, DSE is widely used in the evaluation of myocardial structure and function under physiological and pharmacological stress conditions ([@b6-epj-10-6775], [@b8-epj-10-6775]). In the recent years, the use of this technique has been increased in challenging diagnostic cases due to its perceptual versatility and vast application. SE is simple and available, but it is necessary to follow its training recommendations. Therefore, the application of SE may be less dependent on the experience and interpretation of the operator ([@b6-epj-10-6775]). To detect CAD and its effect on myocardial function, some noninvasive techniques including stress echocardiography, thallium scintigraphy, and dobutamine stress echocardiography are used. Despite their ability to manifest various patterns of left ventricular dysfunction, this procedure could not show the severity of right ventricular (RV) ischemic dysfunction ([@b9-epj-10-6775]). Traditionally, it is believed that right heart only serves as a passive conduit. But recent studies showed that right heart has a crucial role in adequate pulmonary perfusion pressures under various conditions ([@b8-epj-10-6775]). Due to the geometry and kinematics complexity of the assessment of right ventricular (RV) function by SE, it has not been well investigated so far. Therefore, there was no sufficient information about the methodology and quantitating RV function during stress echocardiography ([@b10-epj-10-6775]). As a result, ventricular dysfunction and cardiac failure impose an economic burden on the healthcare systems, especially in developing countries. The appropriate evaluation of RV function and early diagnosis of its failure can lead to timely intervention, reduced economic costs and improvement of outcomes in the acutest patients undergoing coronary artery bypass graft (CABG) surgery ([@b11-epj-10-6775], [@b12-epj-10-6775]). Therefore, the aim of this study was to determine ischemic right ventricular dysfunction in patients with three-vessel CAD by using DSE.

2. Material and Methods
=======================

2.1. Study Design and setting
-----------------------------

This cross-sectional study was among patients (n:13) who were candidates of coronary artery bypass grafting (CABG) referred to Ghaem Hospital, Mashhad, Iran; from September 2015 to May 2016.

2.2. Participants and sampling
------------------------------

Patients with documented 3-vessel CAD and right coronary involvement were included in this study. The cases were diagnosed by a cardiologist during angiography (\>50% stenosis). Patients with any complication during DSE including ventricular and supraventricular tachycardia, monomorphic and polymorphic ventricular and supraventricular extra-systolic beats, AV-block and also patients with the history of cardiac disorders such as right ventricular infarction, any other right heart involvements, pulmonary emboli, pulmonary hypertension and regional wall motion abnormalities of RV and cases affected by chronic obstructive pulmonary disease, were excluded from the study. Cases were enrolled to the study using the purposive sampling method.

2.3. Echocardiography
---------------------

After receiving written consent of all patients, echocardiography was performed with VIVID S5™ (General Electric Healthcare, U.S.A) echocardiogram system. Dobutamine was injected (5 mcg/kg/min) via a pump and increased in intervals of three minutes to 10, 20, 30 and 40 mcg/kg/min to reach the desired heart rate (85% predicted maximum). All echocardiographic parameters (standard and function of right ventricular) were determined. To prevent inter-observer variation, all echocardiographic assessments were done by two cardiologists. During DSE, acute chest pain, hypertension, arrhythmia, or any signs indicating the necessity to stress echocardiography interruption occurred, stress echocardiography was suspended, and consequently, the patient was excluded.

2.4. Statistical analysis
-------------------------

All analyses were carried out using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Categorical measurements were reported as number and percentage. Quantitative measurements were reported as the mean ± SD. Kolmogorov-Smirnov test was used to show the normal distribution of quantitative measurements. Paired-samples t-test was used for comparing the echocardiographic parameters before and after the DSE test. Statistical significance was assessed at a level of 0.05 (two-tailed) for all analyses.

2.5. Research ethics
--------------------

All of the procedure stages, information, possible side effects and context of treatment were explained to the patients and all patients signed written informed consent to participate in the study. In addition, our study was done according to the guideline of the Declaration of Helsinki and also approved by the Ethical Committee of Mashhad University of Medical Sciences, Mashhad, Iran (no: 930756).

3. Results
==========

3.1. Demographic characteristics
--------------------------------

As shown in [Table 1](#t1-epj-10-6775){ref-type="table"}, this study included 13 patients who were CABG (9 male/4 female) with the mean age of 65.4±7.6 years old. The maximum age of participants was 82 years and the minimum age was 56 years. Two patients (15.4%) reported angina, but 11 (84.6%) patients did not have the mentioned cardiac symptom. One patient (7.7%) had post-ejection shortening at the end of stress echocardiography (after ejecting Dobutamine). RV cardiac output decreased in 7 patients (53.8%) at the end of stress echocardiography.

3.2. Echocardiographic parameters
---------------------------------

The mean of RV inlet diameter before injecting Dobutamine was 32.7±5.9 mm (ranged from 22 to 47 mm) in participants ([Table 1](#t1-epj-10-6775){ref-type="table"}). The mean of Systolic right ventricular (SRV) peak before and after DSE was significantly different (8.0±2.2 vs. 13.7±4.2, p\<0.001. However, there was no significant difference between the tricuspid annular plane systolic excursion (TAPS) mean before and after the injection of Dobutamine) 16.9±4.5 vs. 15.7±2.9, p=0.69) ([Figure 1](#f1-epj-10-6775){ref-type="fig"}).

4. Discussion
=============

This study was conducted to evaluate right ventricular ischemia through using DSE in three-vessel CAD. The results showed that TAPS and RV cardiac output can be used to detect right ventricular dysfunction after Dobutamine injection. We studied five major echocardiographic parameters. Three of them demonstrated the RV state (TAPS, SRV, and RV cardiac output), and two parameters indicated the left ventricular function. According to our trend, we focused on the RV parameters. One of the most important issues before and after coronary artery bypass surgery is the evaluation of cardiac ventricles, particularly the right ventricle. Nevertheless, the exact mechanism of contractile dysfunction and left ventricular filling after CABG is not specified ([@b13-epj-10-6775]). Right ventricular dysfunction is a known complication that rapidly appears after cardiac surgery. So identifying the patients with RV dysfunction before the operation is an efficient factor in patients' prognosis ([@b13-epj-10-6775], [@b14-epj-10-6775]). Many studies have concentrated on left ventricle function before and after CABG, but not right ventricle function. The probable reason for the limited studies is the complex anatomy of the right ventricle. Therefore, to date, no gold standard has been set to evaluate the right ventricular function by echocardiography ([@b15-epj-10-6775]). Recording of TAPS is a practical and easy procedure in many patients. However, limited studies considered TAPS as a benchmark in identifying the right ventricular dysfunction before CABG ([@b7-epj-10-6775], [@b9-epj-10-6775], [@b10-epj-10-6775], [@b16-epj-10-6775]). A few studies have shown that the motion of tricuspid valve decreases during systole immediately after CABG. So it is a useful criterion in right ventricular dysfunction ([@b17-epj-10-6775], [@b18-epj-10-6775]). In this present study, the mean of TAPS did not show any RV dysfunction. Interestingly, it reached to 15.7 mm after injecting Dobutamine, which was in the range of RV dysfunction. Although the changes were not statistically significant, it was probably due to the small sample size of this study. It is important to note that these changes would be clinically meaningful and decisive. Of note, in patients who have undergone CABG, in the case of preserved left ventricular function with reduced right ventricular function, an imbalance at the right to left blood flow might be seen. So, the study on right ventricle function before bypass surgery is consequential and TAPS can be used as possible criteria. The other point in this study was the SRV changes. The mean of SRV was 8 and 13.7 mm/s before and after injection of Dobutamine, respectively, which meant no RV dysfunction. In other words, TAPS represents the tricuspid RV dysfunction and SRV reveals a free wall of the right ventricle. In a study, the normal range of estimated SRV pressure at peak exercise during exercise stress echocardiography (ExECHO) was evaluated. The results showed that the SRV should not increase more than 24.6 mmHg in men and 24.5 mmHg in women, respectively. This value is calculated as the increase in pressure SRV plus 2xSD of pressure SRV. The maximum amount of SRV should be 57.4 mmHg in men and 58 mmHg in women. If one of them increases, the SRV response to the test should be considered abnormal ([@b16-epj-10-6775]). We found after Dobutamine infusion, the RV cardiac output in about half of the patients decreased, which showed the considerable role of Dobutamine in determining RV dysfunctions in 3-vessel CAD patients. In this study, the mean of RV inlet diameter obtained 32.5 mm. Based on existing criteria, the inlet diameter of RV that is greater than 35 mm shows dilated RV. In this study, RV size in most patients was in normal range. In a prior study, the RV function was evaluated during SE. for this purpose; the ejection fraction of global RV function was measured. Then radial velocity, circumferential strain and strain rate was used in four parts of RV to evaluate the regional RV function. Finally, they concluded that the quantitative evaluation and regional and global RV is possible during SE and by VVI analysis ([@b10-epj-10-6775]). Although some studies reported the possible side effects of DSE including tachycardia, chest pain, st-segment elevation and myocardial ischemia ([@b19-epj-10-6775]), we have observed no side effect during DSE. The study included 13 patients and the sample size was small compared with similar studies, due to time limitations. However, the gender distribution was proper in our study and 31% of the patients were female while in a similar study only 10% of patients were female ([@b9-epj-10-6775]). The mean age of our patients was nearly similar to other studies. We reported it as 65 years and in other studies, it was 50--60 years ([@b7-epj-10-6775], [@b9-epj-10-6775], [@b10-epj-10-6775], [@b16-epj-10-6775]).

5. Limitations
==============

It was a single center study and the sample size was small and it was similar to a pilot study. According to these results, we recommend a multicenter study with a higher sample size. There is no control group in our study, thus generalizability of the findings is not easily possible. Therefore, further studies are needed by taking a control group. We also suggest that in future investigations, it would be better to assess more echocardiographic variables regarding RV dysfunction.

6. Conclusions
==============

This study suggested that TAPS and RV cardiac output, after Dobutamine injection, can be used as markers for the recognition of ischemic RV dysfunction. Also, there is a need for designing a study which compares the most useful imaging methods for indicating RV dysfunction. Prospective large-scale and randomized clinical trials are suggested to support more evidence-based treatment strategies for future studies.
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![Comparing of systolic right ventricular peak and tricuspid annular plane systolic excursion before and after the stress echocardiography.\
DSE: Dobutamine stress echocardiography; TAPS: tricuspid annular plane systolic excursion; SRV: systolic right ventricular](EPJ-10-6775-g001){#f1-epj-10-6775}
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Demographic and characteristics of the patients.

  Variable                                                                         n (%)[\*](#tfn1-epj-10-6775){ref-type="table-fn"}
  -------------------------------------------------------------------------------- ---------------------------------------------------
  Male                                                                             9 (69.2)
  Age[\*](#tfn1-epj-10-6775){ref-type="table-fn"} (year)                           65.4±7.6
  Angina                                                                           2 (15.4)
  RV inlet diameter[\*](#tfn1-epj-10-6775){ref-type="table-fn"} (mm)               32.7±5.9
  Post injection shortening                                                        1 (7.7)
  TAPS before DSE (mm)[\*](#tfn1-epj-10-6775){ref-type="table-fn"}                 16.9±4.5
  TAPS after DSE (mm)[\*](#tfn1-epj-10-6775){ref-type="table-fn"}                  15.7±2.9
  RV peak systolic before DSE (cm/s)[\*](#tfn1-epj-10-6775){ref-type="table-fn"}   8.0±2.2
  RV peak systolic after DSE (cm/s)[\*](#tfn1-epj-10-6775){ref-type="table-fn"}    13.7±4.2
  Reduced RV output after DSE                                                      7 (53.8)
  Wall motion score index[\*](#tfn1-epj-10-6775){ref-type="table-fn"}              1.3±0.23

Quantitative parameters were expressed as mean ± standard deviation;

RV: right ventricle, DSE: Dobutamine stress echocardiography, TAPS: Tricuspid annular plane systolic excursion
